BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2014-01-20

Reporting Person: Stonehouse Jon P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-20	Common Stock	A	128000	—	Acquired	632360	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-20	Emp. Stock Option (Right to Buy)	$10.80	A	84000	Acquired	2024-01-20	Common Stock (84000)	Direct

Footnotes

F1: Annual Restricted Stock Award. Will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.

F2: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.